231 related articles for article (PubMed ID: 12383103)
1. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma.
Ayman T; Yerebakan O; Ciftçioglu MA; Alpsoy E
Pediatr Dermatol; 2002; 19(5):436-8. PubMed ID: 12383103
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.
Shivaswamy KN; Sumathy TK; Shyamprasad AL; Ranganathan C
Int J Dermatol; 2009 Jul; 48(7):731-3. PubMed ID: 19570079
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases.
Dammak A; Zribi J; Boudaya S; Mseddi M; Meziou TJ; Masmoudi A; Ellouze Z; Keskes H; Turki H
Int J Dermatol; 2009 Jun; 48(6):588-91. PubMed ID: 19538366
[TBL] [Abstract][Full Text] [Related]
4. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma in recessive dystrophic epidermolysis bullosa, presenting as an ulcer that appears to be filled with granulation tissue.
Kalisiak MS; Edwards D; Lin AN
J Cutan Med Surg; 2003; 7(3):229-31. PubMed ID: 12704532
[TBL] [Abstract][Full Text] [Related]
6. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
Yamada M; Hatta N; Sogo K; Komura K; Hamaguchi Y; Takehara K
Dermatol Surg; 2004 Nov; 30(11):1424-9. PubMed ID: 15522026
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa.
Weber F; Bauer JW; Sepp N; Högler W; Salmhofer W; Hintner H; Fritsch P
Acta Derm Venereol; 2001; 81(3):189-92. PubMed ID: 11558875
[TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma developing in a 12-year-old boy with nonHallopeau-Siemens recessive dystrophic epidermolysis bullosa.
Kawasaki H; Sawamura D; Iwao F; Kikuchi T; Nakamura H; Okubo S; Matsumura T; Shimizu H
Br J Dermatol; 2003 May; 148(5):1047-50. PubMed ID: 12786841
[TBL] [Abstract][Full Text] [Related]
9. [Squamous cell carcinoma and recessive dystrophic epidermolysis bullosa].
Fourel E; Claudy AL
Ann Dermatol Venereol; 1992; 119(8):563-5. PubMed ID: 1485760
[TBL] [Abstract][Full Text] [Related]
10. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa.
Kim M; Murrell DF
Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672
[TBL] [Abstract][Full Text] [Related]
11. Inherited epidermolysis bullosa dystrophica and squamous cell carcinoma- A case report.
Gayathri E; Anbukkarasi K; Lilly SM
Indian J Pathol Microbiol; 2023; 66(2):360-362. PubMed ID: 37077084
[TBL] [Abstract][Full Text] [Related]
12. [Squamous cell carcinoma complicating an hereditary epidermolysis bullosa].
Mseddi M; Turki H; Marrekchi S; Abdelmaksoud W; Masmoudi A; Bouassida S; Zahaf A
Cancer Radiother; 2004 Aug; 8(4):266-9. PubMed ID: 15450521
[TBL] [Abstract][Full Text] [Related]
13. MMP13 can be a useful differentiating marker between squamous cell carcinoma and benign hyperkeratotic lesions in recessive dystrophic epidermolysis bullosa.
Hata H; Abe R; Suto A; Homma E; Fujita Y; Aoyagi S; Shimizu H
Br J Dermatol; 2015 Mar; 172(3):769-73. PubMed ID: 25066310
[TBL] [Abstract][Full Text] [Related]
14. Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.
Atanasova VS; Pourreyron C; Farshchian M; Lawler M; Brown CA; Watt SA; Wright S; Warkala M; Guttmann-Gruber C; Hofbauer JP; Fuentes I; Prisco M; Rashidghamat E; Has C; Salas-Alanis JC; Palisson F; Hovnanian A; McGrath JA; Mellerio JE; Bauer JW; South AP
Clin Cancer Res; 2019 Jun; 25(11):3384-3391. PubMed ID: 30846478
[TBL] [Abstract][Full Text] [Related]
15. Reconstruction in RDEB patients.
Huang L; Burd A
Ann Plast Surg; 2009 Dec; 63(6):693; author reply 693. PubMed ID: 19934850
[No Abstract] [Full Text] [Related]
16. Epidermolysis bullosa dystrophica of Hallopeau-Siemens and squamous-cell carcinoma: a case report.
Van Rengen A; Degreef H
Dermatology; 1996; 192(4):418-9. PubMed ID: 8864399
[TBL] [Abstract][Full Text] [Related]
17. Dystrophic epidermolysis bullosa complicated by cutaneous squamous cell carcinoma and pulmonary and renal amyloidosis.
Csikós M; Orosz Z; Bottlik G; Szöcs H; Szalai Z; Rozgonyi Z; Hársing J; Török E; Bruckner-Tuderman L; Horváth A; Kárpáti S
Clin Exp Dermatol; 2003 Mar; 28(2):163-6. PubMed ID: 12653705
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and Outcome of Squamous Cell Carcinoma in Epidermolysis Bullosa in Australia and New Zealand.
Kim M; Li M; Intong-Wheeler LRA; Tran K; Marucci D; Murrell DF
Acta Derm Venereol; 2018 Jan; 98(1):70-76. PubMed ID: 28853495
[TBL] [Abstract][Full Text] [Related]
19. Metastatic squamous cell carcinoma resembling angiosarcoma complicating dystrophic epidermolysis bullosa.
McGrath JA; Schofield OM; Mayou BJ; McKee PH; Eady RA
Dermatologica; 1991; 182(4):235-8. PubMed ID: 1884860
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of insulin-like growth factor-binding protein-3 (IGFBP-3) in Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa.
Mallipeddi R; Wessagowit V; South AP; Robson AM; Orchard GE; Eady RA; McGrath JA
J Invest Dermatol; 2004 May; 122(5):1302-9. PubMed ID: 15140235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]